pgsd
4 minutes ago
Cancer vaccines: platforms and current progress :
10 January 2025
DCVax-L represents another autologous tumor lysate-loaded DC vaccine, notable for its capacity to target a comprehensive antigenic library through tumor lysates, thus optimizing antigen presentation [68, 122, 123